IL162880A0 - Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid - Google Patents

Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid

Info

Publication number
IL162880A0
IL162880A0 IL16288003A IL16288003A IL162880A0 IL 162880 A0 IL162880 A0 IL 162880A0 IL 16288003 A IL16288003 A IL 16288003A IL 16288003 A IL16288003 A IL 16288003A IL 162880 A0 IL162880 A0 IL 162880A0
Authority
IL
Israel
Prior art keywords
chlorophenyk
dichloro
composition containing
medicinal composition
dodecanoic acid
Prior art date
Application number
IL16288003A
Other languages
English (en)
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of IL162880A0 publication Critical patent/IL162880A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16288003A 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid IL162880A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002007022 2002-01-16
PCT/JP2003/000251 WO2003059337A1 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid

Publications (1)

Publication Number Publication Date
IL162880A0 true IL162880A0 (en) 2005-11-20

Family

ID=19191302

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16288003A IL162880A0 (en) 2002-01-16 2003-01-15 Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid

Country Status (20)

Country Link
US (1) US20060051410A1 (xx)
EP (1) EP1473033A1 (xx)
JP (1) JPWO2003059337A1 (xx)
KR (1) KR20040090975A (xx)
CN (1) CN1259909C (xx)
AU (1) AU2003201879B2 (xx)
BR (1) BR0307172A (xx)
CA (1) CA2474014A1 (xx)
EA (1) EA007650B1 (xx)
HR (1) HRP20040718A2 (xx)
IL (1) IL162880A0 (xx)
IS (1) IS7340A (xx)
MX (1) MXPA04006977A (xx)
NO (1) NO20043376L (xx)
NZ (1) NZ534471A (xx)
PL (1) PL373035A1 (xx)
TW (1) TWI252755B (xx)
UA (1) UA80270C2 (xx)
WO (1) WO2003059337A1 (xx)
ZA (1) ZA200406453B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004018634D1 (de) * 2003-05-23 2009-02-05 Kowa Co Carbonsäureverbindung und arzneimittel welches diese enthält
JPWO2005117853A1 (ja) * 2004-06-01 2008-04-03 興和株式会社 高脂血症治療剤及び糖尿病治療剤
EP1772149A1 (en) * 2004-07-27 2007-04-11 Kowa Company. Ltd. Drug for prevention or treatment of diabetes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa

Also Published As

Publication number Publication date
NO20043376L (no) 2004-08-13
CN1612730A (zh) 2005-05-04
CN1259909C (zh) 2006-06-21
TW200302079A (en) 2003-08-01
PL373035A1 (en) 2005-08-08
US20060051410A1 (en) 2006-03-09
MXPA04006977A (es) 2005-04-19
UA80270C2 (en) 2007-09-10
EA200400954A1 (ru) 2004-12-30
BR0307172A (pt) 2004-11-03
EA007650B1 (ru) 2006-12-29
WO2003059337A1 (en) 2003-07-24
KR20040090975A (ko) 2004-10-27
CA2474014A1 (en) 2003-07-24
AU2003201879B2 (en) 2007-09-13
AU2003201879A1 (en) 2003-07-30
IS7340A (is) 2004-06-30
TWI252755B (en) 2006-04-11
HRP20040718A2 (en) 2004-12-31
JPWO2003059337A1 (ja) 2005-05-19
NZ534471A (en) 2005-08-26
ZA200406453B (en) 2006-06-28
EP1473033A1 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
HK1077515A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
HK1183446A1 (en) Stable pharmaceutical composition containing factor viii viii
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
IL153907A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 2-METHYLENE-19-NOR-20(S)-1alpha, 25-DIHYDROXYVITAMIN D3
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HK1077296A1 (en) 2,5-Disubstituted 3-mercaptopentanoic acid
HUP0203275A3 (en) 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
TWI347948B (en) Novel 2',5'-oligoadenylic acid compositions
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
HK1081451A1 (en) Medicinal composition
IL162880A0 (en) Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyk) dodecanoic acid
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
HUP0203454A3 (en) Novel fusidic acid derivatives, pharmaceutical compositions containing them and their use
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
AU2003275360A8 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
IL146812A0 (en) Streptogramin derivatives, production thereof and compositions containing the same
HK1062274A1 (en) Medicinal composition
AU2003284769A1 (en) 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same